Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 22.36
1.36 %
$ 1.03 B
Market Cap
-11.29
P/E
PCRX - STOCK-BASED COMPENSATION
Stock-based Compensation PCRX - Pacira BioSciences, Inc.
47.9 M
LAST VALUE
6.48%
2 YEAR CAGR
8.59%
5 YEAR CAGR
15.32%
10 YEAR CAGR